Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents and analgesics. Its structure supports the creation of peptidomimetic compounds, which can mimic natural peptides and enhance metabolic stability in drug design. Commonly employed in research settings for constructing complex molecules requiring chiral amino acid derivatives with lipophilic side chains. Also utilized in the preparation of bioactive molecules where a constrained cyclohexyl group improves receptor binding selectivity.